Term
Vertical transmission
[aka mother-to-child transmission (MTCT)] |
|
Definition
| Transmission of disease from parent to offspring |
|
|
Term
Post-exposure prophylaxis
(PEP) |
|
Definition
| Preventative administration of antiretroviral agents following a high risk exposure |
|
|
Term
| Pre-exposure prophylaxis (PrEP) |
|
Definition
| Administration of antiretroviral agents to decrease the risk of transmission of virus |
|
|
Term
|
Definition
| Cancer caused by overgrowth of blood vessels, causing pink/purple bumps on skin; can also occur internally (intestines, lymph nodes, and lungs) |
|
|
Term
|
Definition
| Exposure to potentially infectious material while at work |
|
|
Term
|
Definition
| Any illness, when occurring in an HIV-infected patient, that leads to an AIDS diagnosis |
|
|
Term
|
Definition
| A temporary increase in viral load (usually 50-500 copies/ml) in someone who previously had undetectable virus and who later returns to having undetectable virus |
|
|
Term
| Booster, Boosting, Boosted |
|
Definition
| When referring to ART: A medicine (usually Ritonavir) given to enhance another medicine |
|
|
Term
|
Definition
| Progression of disease as measured by deterioration of clinical outcomes |
|
|
Term
|
Definition
| Loss of body fat from particular areas of the body |
|
|
Term
|
Definition
| Problem with the way the body produces, uses, and/or distributes fat |
|
|
Term
|
Definition
|
|
Term
Maintenance therapy
(aka secondary prophylaxis) |
|
Definition
| Medication given to prevent a treated infection from returning after having been controlled |
|
|
Term
|
Definition
| An illness caused by any one of various organisms that occur in immunosuppressed patients |
|
|
Term
|
Definition
| HIV-infected individual’s CD4 count decreases below the baseline or does not increase above baseline after 1 year of antiretroviral therapy |
|
|
Term
|
Definition
| Medication given to prevent a first episode of infection |
|
|
Term
| Immune Reconstitution Inflammatory Syndrome (IRIS) |
|
Definition
| A collection of inflammatory disorders associated with paradoxical worsening of preexisting infectious processes following the initiation of highly active antiretroviral therapy (HAART) in HIV-infected individuals |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Inflammation of esophagus |
|
|
